EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human iPSCs as Model Systems for BMP-Related Rare Diseases

Gonzalo Sánchez-Duffhues iD, Christian Hiepen iD

Cells · 02.09.2023 · 12 (17) · 2200

DOI: 10.3390/cells12172200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 02.09.2023. Verfasst von Gonzalo Sánchez-Duffhues und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nanomaterials and Nanotechnology Research Center (CINN-CSIC), ISPA-HUCA, Avda. de Roma, s/n, 33011 Oviedo, Spain. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 287 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publication Fund of the Westphalian University of Applied Sciences, Fundació La Marató de TV3, Ramón y Cajal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disturbances in bone morphogenetic protein (BMP) signalling contribute to onset and development of a number of rare genetic diseases, including Fibrodysplasia ossificans progressiva (FOP), Pulmonary arterial hypertension (PAH), and Hereditary haemorrhagic telangiectasia (HHT). After decades of animal research to build a solid foundation in understanding the underlying molecular mechanisms, the progressive implementation of iPSC-based patient-derived models will improve drug development by addressing drug efficacy, specificity, and toxicity in a complex humanized environment. We will review the current state of literature on iPSC-derived model systems in this field, with special emphasis on the access to patient source material and the complications that may come with it. Given the essential role of BMPs during embryonic development and stem cell differentiation, gain- or loss-of-function mutations in the BMP signalling pathway may compromise iPSC generation, maintenance, and differentiation procedures. This review highlights the need for careful optimization of the protocols used. Finally, we will discuss recent developments towards complex in vitro culture models aiming to resemble specific tissue microenvironments with multi-faceted cellular inputs, such as cell mechanics and ECM together with organoids, organ-on-chip, and microfluidic technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsAnimalsFemalePregnancyHumansRare DiseasesBone Morphogenetic ProteinsCell DifferentiationDrug Development

Stichwörter der Autor:innen

FAPFOPHHTPAHTGF-beta

Substanzen

Bone Morphogenetic Proteins

Autor:innen und Institutionen

  • Nanomaterials and Nanotechnology Research Center (CINN-CSIC), ISPA-HUCA, Avda. de Roma, s/n, 33011 Oviedo, Spain.
  • Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands.
  • Department of Engineering and Natural Sciences, Westphalian University of Applied Sciences, August-Schmidt-Ring 10, 45665 Recklinghausen, Germany.

ORCID-Profile: Gonzalo Sánchez-Duffhues, Christian Hiepen

Förderung

  • Open Access Publication Fund of the Westphalian University of Applied Sciences
  • Fundació La Marató de TV3
  • Ramón y Cajal
  • PROMETHEUS
  • Research Foundation–Flanders
  • An Zwijsen

Zitieren

APA

Sánchez-Duffhues, G., & Hiepen, C. (2023). Human iPSCs as Model Systems for BMP-Related Rare Diseases. Cells, 12(17), 2200. https://doi.org/10.3390/cells12172200

Vancouver

Sánchez-Duffhues G, Hiepen C. Human iPSCs as Model Systems for BMP-Related Rare Diseases. Cells. 2023;12(17):2200. doi:10.3390/cells12172200

BibTeX
@article{SnchezDuffhues2023,
  author = {Sánchez-Duffhues, Gonzalo and Hiepen, Christian},
  title = {Human iPSCs as Model Systems for BMP-Related Rare Diseases},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {17},
  pages = {2200},
  doi = {10.3390/cells12172200}
}
Kostenlos starten →